Representative before the EPO

Company dna sagittarius ip
no operation time available
1 office
active in Legal Services

Mark Gibson has worked on the following 184 EPO patent applications which have been published in the last five years:

EP11728491

D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE

IPC classification:
A61K 31/438, A61P 1/08, C07D 471/10
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP11733325

HEAT TRANSFER INTERFACE

IPC classification:
B01J 13/16
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP10803479

METHODS FOR INCREASING METHANOGENESIS IN SUBSURFACE RESERVOIRS

IPC classification:
C09K 8/582, C12P 5/02
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11743404

NORIBOGAINE COMPOSITIONS

IPC classification:
A61K 31/55, C07D 487/22
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11736145

METHOD FOR DETECTING THE PRESENCE OF A GYNAECOLOGICAL GROWTH

IPC classification:
G01N 33/53, G01N 33/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11766955

METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES

IPC classification:
A61K 39/00, A61K 39/385, A61K 47/48, G01N 33/543, G01N 33/564
Applicant:
UTI Limited Partnership
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP12189943

Non-surgical removal of localized fat accumulation with a bile salt in conjunction with an analgesic or anti-inflammatory agent

IPC classification:
A61K 9/00, A61K 31/222, A61K 31/575, A61K 31/60, A61K 45/06, A61P 3/00, A61Q 19/06
Applicant:
The Regents of the University of California
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11781368

METHODS AND DEVICES FOR DIAGNOSING ALZHEIMERS DISEASE

IPC classification:
C12Q 1/68, G01N 33/68
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12757601

A METHOD OF VACCINATION COMPRISING A HISTONE DEACETYLASE INHIBITOR

IPC classification:
A61K 35/76, A61K 39/39, A61P 37/04
Applicant:
McMaster Industry Liaison Office
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP09714281

BACILLUS SUBTILIS AND USE THEREOF AS A GREEN MOLD INHIBITOR

IPC classification:
A01G 1/04, A01M 7/00, A01N 25/02, A01N 63/00, A01P 3/00, C12N 1/20
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12717460

BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY

IPC classification:
C07D 401/06, C07D 471/04, C07D 471/10
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12717459

BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY

IPC classification:
A61K 31/437, A61K 31/4985, A61K 31/519, A61K 31/5383, A61P 35/00, C07D 471/04, C07D 498/04
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12779785

EXCIPIENT COMPATIBILITY WITH EZATIOSTAT

IPC classification:
A61K 9/16, A61K 9/20, A61K 38/06, A61K 47/38
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12189947

Methods and related compositions for reduction of fat

IPC classification:
A61K 8/63, A61K 31/575, A61K 31/685, A61P 3/00, A61Q 19/06
Applicant:
The Regents of the University of California
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12728907

THERAPEUTIC AGENTS FOR REGULATING SERUM PHOSPHORUS

IPC classification:
A61K 38/08, A61P 13/12
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP12746213

N-ACETYL-D-GLUCOSAMINE FOR ENHANCED SPECIFICITY OF STREP A IMMUNOASSAY

IPC classification:
G01N 33/543, G01N 33/558, G01N 33/569
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12753864

COMPOSITIONS AND METHODS FOR SPECIFIC REGULATION OF PYRUVATE DEHYDROGENASE KINASE

IPC classification:
C07K 7/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12756603

NEW AAV CAPSID PROTEINS FOR NUCLEIC ACID TRANSFER

IPC classification:
C07K 14/005, C12N 7/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION REFUSED
EP12827083

MODULAR, SCALABLE SPILL CONTAINMENT LINING SYSTEM

IPC classification:
E02D 31/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12756549

METHOD FOR DETECTING NUCLEOSOMES CONTAINING NUCLEOTIDES

IPC classification:
G01N 33/574
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12762367

METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS

IPC classification:
G01N 33/574, G01N 33/68
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12829666

INFECTION ACTIVATED WOUND CARING COMPOSITIONS AND DEVICES

IPC classification:
A61L 15/00, C12Q 1/70
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12830857

INDUSTRIAL WATER PURIFICATION AND DESALINATION

IPC classification:
C02F 1/04, C02F 1/52, C02F 1/66, C02F 9/08, C02F 103/08
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13153888

Compositions and methods for the prevention and treatment of autoimmune conditions

IPC classification:
A61K 39/00, A61K 39/385, A61P 37/00, A61P 37/06
Applicant:
UTI Limited Partnership
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12838765

GERANYLGERANYLACETONE DERIVATIVES

IPC classification:
C07C 49/08, C07C 49/203, C07C 49/21, C07C 49/395
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13190133

Aryl gpr120 receptor agonists and uses thereof

IPC classification:
A61K 31/4155, A61K 31/4164, A61K 31/42, C07D 231/12, C07D 233/64, C07D 249/06, C07D 261/08, C07D 263/32, C07D 277/24, C07D 285/06, C07D 307/42, C07D 333/16, C07D 409/04
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12778672

MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY

IPC classification:
C07K 1/107, C40B 40/02
Agent:
Mark Gibson, Sagittarius IP
Agent:
Antonio Maschio, Maschio & Soames IP Limited
Status:
GRANT OF PATENT INTENDED
EP12791926

CALCIMIMETICS AND METHODS FOR THEIR USE

IPC classification:
A61K 38/08, A61P 5/20, A61P 13/12, A61P 19/00
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP12704978

VASCULAR PLAQUE REMOVAL SYSTEMS, DEVICES, AND METHODS

IPC classification:
A61B 17/221, A61B 17/3207
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12747416

TREATMENT OF SUBMENTAL FAT

IPC classification:
A61K 31/56, A61P 41/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP12853218

AMORPHOUS EZATIOSTAT ANSOLVATE

IPC classification:
A61K 31/19, A61P 35/00, C07C 321/20
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12854847

PHOSPHATE ESTERS OF NORIBOGAINE

IPC classification:
A61K 31/65, A61K 31/675
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12764414

EZATIOSTAT FOR TREATING MULTIPLE MYELOMA

IPC classification:
A61K 38/06, A61K 38/07, A61P 35/02
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12859513

SELF-SEALING CATHETERS

IPC classification:
A61M 25/00, A61M 31/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12810417

2 - (PYRIDIN- 2YL) - 1, 7 -DIAZA- SPIRO [4.4]NONANE- 6 -ONE COMPOUNDS AS VOLTAGE - GATED SODIUM CHANNELS MODULATORS

IPC classification:
A61K 31/407, A61P 25/00, A61P 29/00, C07D 487/10
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12816093

DIAGNOSTIC TEST FOR BACTERIAL PATHOGENS USING INTERNAL CONTROL BACTERIAL STRAIN

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP12859455

CROSS-LINKED DEHYDRATED PLACENTAL TISSUE GRAFTS AND METHODS FOR MAKING AND USING THE SAME

IPC classification:
A61F 2/02
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12810416

2 - (PYRIDIN- 2YL) - 1, 7 -DIAZA-SPIRO [4.4]NONANE- 6 -ONE COMPOUND AS VOLTAGE-GATED SODIUM CHANNELS MODULATOR

IPC classification:
A61K 31/407, A61P 25/00, A61P 29/00, C07D 487/10
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12852900

APPARATUS AND METHOD FOR TREATING AQUEOUS SOLUTIONS AND CONTAMINANTS THEREIN

IPC classification:
C02F 1/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14171739

Genetically modified human natural killer cell lines

IPC classification:
C07K 14/705, C12N 5/00
Agent:
Mark Gibson, Sagittarius IP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14169643

Strip ejection system

IPC classification:
A61B 5/00, B65D 83/08, B65H 29/00, G01N 33/48, G01N 33/487, G01N 33/50, G01N 33/52
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14170410

Biomarkers for schizophrenia or other psychotic disorders

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13741387

(1R,4R) 7-OXO-2-AZABICYCLO[2.2.2]OCT-5-ENE AND DERIVATIVES THEREOF

IPC classification:
A61K 31/46, C07D 451/04, C07D 491/10, C07D 495/10
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13740942

SYNTHETIC VOACANGINE

IPC classification:
A61K 31/55, A61P 25/04, C07D 487/18, C07D 487/22
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13741381

INDOLE AND BENZOFURAN FUSED ISOQUINUCLIDENE DERIVATIVES AND PROCESSES FOR PREPARING THEM

IPC classification:
A61K 31/439, C07D 487/14, C07D 487/22, C07D 491/147
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12852862

PLACENTAL TISSUE GRAFTS PRODUCED BY CHEMICAL DEHYDRATION/FREEZE-DRYING AND METHODS FOR MAKING AND USING SAME

IPC classification:
A01N 1/00, A61K 35/50, C12N 5/071
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12856663

TRISUBSTITUTED METHYL ALCOHOLS AND THEIR POLYMERIZABLE DERIVATIVES

IPC classification:
C07C 41/34, C07C 41/58, C07C 43/20
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14155614

Formulations of deoxycholic acid and salts thereof

IPC classification:
A61K 31/575, A61P 3/04
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14155911

Cell culture system for determining the sensitizing, allergenic and/or irritating effect of a substance

IPC classification:
G01N 33/50
Agent:
Christoph Gerspacher, Patentanwälte Ruff, Wilhelm, Beier, Dauster & Partner mbB
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13711996

INTERACTIVE TEST DEVICE AND APPARATUS WITH TIMING MECHANISM

IPC classification:
G01N 33/52, G01N 33/558
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13709986

METHOD OF IDENTIFYING VDJ RECOMBINATION PRODUCTS

IPC classification:
C07K 16/00, C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12781802

CANCER TREATMENTS

IPC classification:
A61K 9/51, A61K 31/337, A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/22
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13717620

CONTAINER AND SYSTEM FOR SAMPLE COLLECTION AND PREPARATION

IPC classification:
B01L 3/00
Applicant:
Northwestern University
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14190691

Casein kinase 1delta (CK1delta) inhibitors

IPC classification:
A61K 31/00, A61K 31/437, A61K 31/4439, A61K 31/506, A61P 25/28
Agent:
Multiple attorneys, Proteome Sciences plc
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12866861

SYSTEMS AND METHODS FOR MAINTAINING FOODS

IPC classification:
A23L 2/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14184505

Compositions and methods for the prevention and treatment of autoimmune conditions

IPC classification:
A61K 39/00, A61K 39/385, A61K 47/48, A61P 37/00, A61P 37/06, G01N 33/543, G01N 33/564
Applicant:
UTI Limited Partnership
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13784125

SYSTEM, METHOD, AND COMPUTER ALGORITHM FOR CHARACTERIZATION AND CLASSIFICATION OF ELECTROPHYSIOLOGICAL EVOKED POTENTIALS

IPC classification:
A61B 5/0484
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12197999

Substituted Thiazoles as VEGFR2 kinase Inhibitors

IPC classification:
A61K 31/427, A61K 31/506, A61P 35/00, C07D 417/04
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13725240

CARTRIDGE FOR USE IN AN AUTOMATED SYSTEM FOR ISOLATING AN ANALYTE FROM A SAMPLE, AND METHODS OF USE

IPC classification:
B01L 3/00
Applicant:
Northwestern University
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP13723640

DEVICE FOR ISOLATING AN ANALYTE FROM A SAMPLE, AND METHODS OF USE

IPC classification:
B01L 3/00, G01N 35/00
Applicant:
Northwestern University
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP11178538

Formulations of Deoxycholic Acid and Salts Thereof

IPC classification:
A61K 31/575, A61P 3/04
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13793866

METHOD OF DIAGNOSING CANCER COMPRISING DETECTION OF THE METHYLATION SIGNATURE IN THE HTERT PROMOTER

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13725458

TTC8 AS PROGNOSTIC GENE FOR PROGRESSIVE RETINAL ATROPHY IN DOGS

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13725438

NOVEL COMPOUNDS

IPC classification:
A61K 31/407, A61P 25/00, C07D 487/10
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP13725439

NOVEL COMPOUNDS

IPC classification:
A61K 31/407, A61K 31/438, A61P 25/00, C07D 471/10, C07D 487/10
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP11731159

PREPARATION OF CRYSTALLINE EZATIOSTAT HYDROCHLORIDE ANSOLVATE FORM D

IPC classification:
A61K 38/06, A61P 35/00, C07K 5/02
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13745881

BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS

IPC classification:
G01N 33/569
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11718774

NOVEL COMPOUNDS

IPC classification:
A61K 31/438, A61P 29/00, C07D 471/10
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11718773

SPIROCYCLIC DERIVATIVES WITH AFFINITY FOR CALCIUM CHANNELS

IPC classification:
A61K 31/438, A61P 29/00, C07D 471/10
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13829807

MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A01N 63/00, A61K 35/66
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13830009

REINFORCED PLACENTAL TISSUE GRAFTS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61F 2/02, A61F 2/04, A61L 27/14, C12N 5/071
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13759286

METHOD OF DETECTING CHROMOSOMAL ABNORMALITIES

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12747175

LAMINATED TISSUE GRAFTS COMPOSED OF WHARTON'S JELLY AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61F 2/02, A61L 27/36, A61L 27/50
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP15158273

System for fermentation of biomass for the production of ethanol

IPC classification:
C12M 1/00, C12P 7/10
Agent:
Mark Gibson, Sagittarius IP
Status:
The patent has been granted
EP12184429

Method for producing ethanol using raw starch

IPC classification:
A23L 1/105, C12C 1/00, C12C 7/04, C12F 3/10, C12P 1/00, C12P 1/02, C12P 7/02, C12P 7/06
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13838607

SYSTEMS AND METHODS FOR ENZYME DETECTION

IPC classification:
B01L 3/00, B82Y 15/00, C12M 1/40, C12N 9/50
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP11707986

CRYSTALLINE EZATIOSTAT HYDROCHLORIDE ANSOLVATE

IPC classification:
A61K 38/06, A61P 35/00, C07K 5/02
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13840378

DEVICE AND METHODS FOR SUSTAINED RELEASE OF ANTIPSYCHOTIC MEDICATIONS

IPC classification:
A61K 9/16, A61K 9/22, A61K 31/519, A61K 47/30, A61P 25/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13840551

MEDICATION DELIVERY, DOSING AND SAFETY DEVICES, SYSTEMS AND KITS, AND METHODS OF USING THE SAME

IPC classification:
A61B 19/04, A61M 35/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13843209

CANCER TREATMENTS

IPC classification:
A61K 31/282, A61K 31/337, A61K 39/395, A61K 45/06, A61P 35/00, B82Y 5/00
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12179172

Methods for Treating Myelodysplastic Syndrome with Ezatiostat

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13777330

DIAGNOSTIC METHOD FOR COLORECTAL CANCER

IPC classification:
G01N 33/564, G01N 33/574, G01N 33/66, G01N 33/68, G01N 33/80
Applicant:
Origin Sciences Limited
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13851728

THERAPY FOR CONSTIPATION

IPC classification:
A61K 31/365, A61K 31/536, A61P 1/10
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13855933

CROSS-LINKED COLLAGEN COMPRISING METALLIC ANTICANCER AGENTS

IPC classification:
A61K 38/17, A61P 35/04, C07K 14/78
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP15150984

Genetically modified human natural killer cell lines

IPC classification:
C07K 14/705, C12N 5/00, C12N 5/0783
Agent:
Mark Gibson, Sagittarius IP
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13854317

CROSS-LINKED COLLAGEN WITH A BOUND ANTIMICROBIAL AGENT

IPC classification:
A61K 9/00, A61K 38/17, A61P 31/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13854737

ELECTROCHEMICAL DETERMINATION OF INFECTION

IPC classification:
A61B 5/053, A61B 5/145, C12Q 1/04
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13857431

TREATMENT OF GLUTEN INTOLERANCE AND RELATED CONDITIONS

IPC classification:
A61K 36/36, A61K 38/48, A61P 1/14
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13808199

NOVEL METHOD

IPC classification:
C12N 5/0735, C12N 5/074, C12N 9/02
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12890228

SUBSTITUTED NORIBOGAINE

IPC classification:
A61K 31/55
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14702109

DEOXYURIDINE TRIPHOSPHATASE INHIBITORS

IPC classification:
A61K 31/445, A61P 35/00, C07D 211/88, C07D 215/26, C07D 231/56, C07D 239/54, C07D 265/18, C07D 277/36, C07D 401/06, C07D 401/12, C07D 403/06, C07D 471/04
Applicant:
University of Southern California
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14740998

METHODS FOR TREATING CARDIAC CONDITIONS

IPC classification:
A61K 35/50, A61P 9/00, C12N 5/073
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14749161

APPARATUS AND METHOD FOR TREATING AQUEOUS SOLUTIONS AND CONTAMINANTS THEREIN

IPC classification:
C02F 1/32
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14704880

SYSTEMS AND METHODS FOR EARLY DISEASE DETECTION AND REAL-TIME DISEASE MONITORING

IPC classification:
A61B 5/00, G01N 33/50
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11701861

Biomarkers

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12739994

CAMERA ASSEMBLY FOR THE EXTRACTION OF IMAGE DEPTH DISCONTINUITY AND METHOD OF USE

IPC classification:
G01B 11/22, G01B 11/24, G01B 11/245, H04N 5/222, H04N 13/02
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14775177

NANOPIPETTE DEVICE AND METHOD FOR SUBCELLULAR ANALYSIS

IPC classification:
C12M 1/34, C12N 5/00, G01N 33/53
Applicant:
The Regents of the University of California
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14712530

METHOD OF TREATING INFECTIONS, DISEASES OR DISORDERS OF NAIL UNIT

IPC classification:
A61K 9/00, A61M 37/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14765049

INTRAVENOUS EMULSIONS OF TRIPTOLIDE AS IMMUNOMODULATORS AND ANTICANCER AGENTS I

IPC classification:
A61K 9/107, A61K 31/34, A61K 31/57
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14764291

MOLDED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61K 35/50
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP13880549

FAST MAGNETIC RESONANCE IMAGING METHOD AND SYSTEM

IPC classification:
A61B 5/055, G01R 33/56
Applicant:
Shenzhen Institute of Advanced Technology - Chinese Academy of Sciences
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14782795

USE OF ANTIBODY-UREASE CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES

IPC classification:
A61K 47/48, A61P 35/00, C07K 16/00, C07K 16/28, C12N 9/80, C12N 9/96
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14730083

MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY

IPC classification:
A61K 47/48
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14783309

NDGA POLYMERS AND METAL COMPLEXES THEREOF

IPC classification:
A61K 31/045, A61K 31/047, A61K 31/05, A61P 35/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14719823

NOVEL BIOMARKERS

IPC classification:
A61K 38/21, C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12174635

GPR120 receptor agonists and uses thereof

IPC classification:
A61K 31/343, A61P 5/50, C07D 213/64, C07D 231/56, C07D 235/12, C07D 307/79, C07D 307/83, C07D 311/58, C07D 319/08, C07D 333/54, C07D 407/04
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11838947

BIOMARKERS FOR PREDICTING PROGRESSIVE JOINT DAMAGE

IPC classification:
C12Q 1/68, G01N 33/564, G06F 7/60
Agent:
Mark Gibson, Sagittarius IP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14725241

MARKER FOR RESPONSE TO ANTIDEPRESSANT THERAPY

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Craig Edward Titmus, Mathys & Squire LLP
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14763905

TREATMENT OF GLUTEN INTOLERANCE AND RELATED CONDITIONS

IPC classification:
A61K 38/48, A61P 1/14, A61P 31/04, C12N 9/50, A23L 33/00
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13885866

POLYMER CHELATOR CONJUGATES

IPC classification:
A61K 31/785, A61K 38/17, A61P 35/04
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14742093

STABLE LIQUID FORMULATION OF AMG 416 (VELCALCETIDE)

IPC classification:
A61K 9/08, A61K 38/08, A61P 3/14, A61P 5/00
Applicant:
Amgen Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP14822527

EMBRYO CULTURE METHODS AND MEDIA

IPC classification:
C12N 5/02, C12N 5/0735
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP11721351

BIOMARKERS

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14752914

PREDICTIVE METHOD FOR BONE FRACTURE RISK IN HORSES AND HUMANS

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12701164

PIPERAZINE DERIVATIVES AS CAV2.2 CALCIUM CHANNEL BLOCKERS

IPC classification:
A61K 31/4985, A61P 3/14, C07D 487/14
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11804756

ASK1 INHIBITING PYRROLOPYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/519, A61P 29/00, C07D 487/04
Agent:
Mark Gibson, Sagittarius IP
Status:
PATENT GRANTED
EP14838972

MICRONIZED PLACENTAL COMPOSITIONS COMPRISING A CHELATOR

IPC classification:
A61K 9/16, A61K 35/50, A61K 47/30
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP15202046

PURIFIED DEOXYCHOLIC ACID AND ITS COSMETIC USE IN THE NON-SURGICAL REMOVAL OF UNDESIRABLE FAT DEPOSITS

IPC classification:
A61K 31/575, C07J 1/00, C07J 5/00, C07J 9/00, C07J 13/00, C07J 41/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14765989

CHROMOSOME CONFORMATION CAPTURE METHOD INCLUDING SELECTION AND ENRICHMENT STEPS

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14843594

COSMETIC USES OF MOLDED PLACENTAL COMPOSITIONS

IPC classification:
A61K 8/72, A61K 8/98, A61Q 19/00, A61Q 19/08
Agent:
Mark Gibson, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14845560

METHOD FOR ASSAYING A PROTEASE

IPC classification:
C12N 9/12, C12N 9/50, C12N 9/64, C12N 9/74, C12Q 1/37, C12Q 1/56, G01N 33/48, G01N 33/52, G01N 33/542, G01N 33/58
Applicant:
McMaster University
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11738465

TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS

IPC classification:
A61K 31/41, A61P 23/00, C07D 257/06, C07D 401/14, C07D 403/06, C07D 413/06, C07D 471/10, C07D 487/04, C07D 487/08, C07D 491/08, C07D 513/04
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10798829

BIOMARKERS

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10798830

Biomarkers

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14856528

GENE FOR INDUCTION OF PARTHENOGENESIS, A COMPONENT OF APOMICTIC REPRODUCTION

IPC classification:
A01H 1/00, C12N 5/04, C12N 5/14
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP11731158

INTRAOCULAR LENSES WITH HIGH CONTRAST HAPTICS, MATERIALS, AND METHODS

IPC classification:
A61F 2/16, B29D 11/02
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11712659

BIOMARKERS FOR SCHIZOPHRENIA

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13896941

ELUTING MATRIX AND USES THEREOF

IPC classification:
A61K 9/00, A61K 38/00, A61K 47/42, A61P 3/10, A61P 37/00
Applicant:
The General Hospital Corporation
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP11804760

DETECTION OF QUANTITATIVE GENETIC DIFFERENCES

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14821017

METHOD FOR REDUCING ANALYZER VARIABILITY USING A NORMALIZATION TARGET

IPC classification:
G01N 21/27, G01N 21/64, G01N 33/558
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP11707238

APPARATUS AND METHOD FOR TREATING WET SOLIDS FROM A FERMENTATION PROCESS

IPC classification:
A23K 1/06, B01D 11/02, C12M 1/00, C12P 7/06, C12P 7/10
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14815838

BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY

IPC classification:
A61K 31/437, A61P 35/00, C07D 471/04
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15733304

HETEROATOM CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS

IPC classification:
C07D 241/08, C07D 241/18, C07D 403/12
Applicant:
University of Southern California
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15737660

METHOD FOR INDUCING ANGIOGENESIS

IPC classification:
A61K 35/50, C12N 5/073
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15702571

BIOMARKERS

IPC classification:
G01N 33/569
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP10836551

MODULAR, SCALABLE LIQUID MANAGEMENT SYSTEM

IPC classification:
E02B 5/02, E02B 13/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP16177700

NOVEL COMPOUNDS

IPC classification:
A61K 31/506, C07D 487/10
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14883031

METHODS FOR ACUTE AND LONG-TERM TREATMENT OF DRUG ADDICTION

IPC classification:
A61K 31/55, A61P 25/04, A61P 25/30
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15758129

THERAPEUTIC USES OF IBOGAINE AND RELATED COMPOUNDS

IPC classification:
A61K 31/404, A61K 31/4738, A61K 31/55, A61P 25/30, A61P 25/34
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP11704846

OLIGONUCLEOTIDE BASED ANALYTE DETECTION METHOD

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11700576

PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS

IPC classification:
A61K 31/496, A61P 25/02, A61P 29/00, C07D 217/26, C07D 251/48, C07D 401/06
Agent:
Mark Gibson, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15762030

COMPOSITIONS AND METHODS FOR TREATING, INCLUDING PREVENTING, PARVOVIRUS INFECTIONS AND RELATED DISEASES

IPC classification:
A61K 39/23, C07H 21/04, C12N 15/00, C12Q 1/68, C12Q 1/70
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15710233

NOVEL BIOMARKERS

IPC classification:
G01N 33/68
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15717307

WIRELESS SYSTEM FOR NEAR REAL TIME SURVEILLANCE OF DISEASE

IPC classification:
G06F 19/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15773570

METHOD FOR PREPARING AMG 416

IPC classification:
A61K 38/08, C07K 1/02, C07K 7/00
Applicant:
Amgen Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15772723

BIOMARKERS AND METHODS FOR MEASURING AND MONITORING JUVENILE IDIOPATHIC ARTHRITIS ACTIVITY

IPC classification:
C12Q 1/68, G01N 33/68, G06F 19/10
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15716570

NAT10 MODULATORS FOR TREATING OR PREVENTING LAMINOPATHIES, AGING AND CANCER

IPC classification:
A61K 31/426, A61K 31/549, A61K 45/06, A61P 9/00, A61P 17/00, A61P 35/00, A61P 39/00, A61P 43/00, A61Q 19/08, C07D 277/50, C07D 285/18
Applicant:
Cambridge Enterprise Ltd.
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15785451

A NOVEL AFFINITY MATRIX AND DEVICES FOR ISOLATION AND PURIFICATION OF RNA AND DNA FOR POINT OF CARE MOLECULAR DEVICES

IPC classification:
C12N 15/10
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16192596

D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE

IPC classification:
A61K 31/438, A61P 1/08, C07D 471/10
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION PUBLISHED
EP16192999

COMPOSITIONS CONTAINING DEOXYCHOLIC ACID AND C1-3-ALCOHOLS, DIRECTED TO THE PURIFICATION OF DEOXYCHOLIC ACID

IPC classification:
A61K 31/575, A61P 3/04, C07J 9/00
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION PUBLISHED
EP15724353

GLYCOLIPID CONTAINING COMPOSITIONS FOR USE IN THE TREATMENT OF TUMOURS

IPC classification:
A61K 31/7032, A61P 35/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16196258

NEW AVV CAPSID PROTEINS FOR NUCLEIC ACID TRANSFER

IPC classification:
C07K 14/015, C12N 7/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION PUBLISHED
EP15796851

MICRONIZED WHARTON'S JELLY

IPC classification:
C12N 5/00
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15728100

DIAGNOSTIC METHOD

IPC classification:
C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15733015

COMBINATION THERAPY COMPRISING A LIPOSOMAL PRODRUG OF MITOMYCIN C AND RADIOTHERAPY

IPC classification:
A61K 9/127, A61P 35/00, A61K 47/50
Applicant:
The University of North Carolina at Chapel Hill
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15809075

TREATING MYELOMAS

IPC classification:
A61P 31/00, A61K 47/50
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15806443

TREATING LYMPHOMAS

IPC classification:
A61K 31/555, A61K 39/395
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15731094

NOVEL METHOD

IPC classification:
C07K 14/705, C07K 14/71, C12N 15/85
Applicant:
Cambridge Enterprise Ltd.
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15806913

BIOMARKERS AND METHODS FOR MEASURING AND MONITORING AXIAL SPONDYLOARTHRITIS DISEASE ACTIVITY

IPC classification:
G01N 33/68, G06F 19/20, G06F 19/28
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15812274

SYSTEM FOR ASSESSING GLOBAL WELLNESS

IPC classification:
G01N 33/50
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14890017

N-SUBSTITUTED NORIBOGAINE PRODRUGS

IPC classification:
A61K 31/55, C07D 487/04, C07D 487/12
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15819525

MICRONIZED WHARTON'S JELLY

IPC classification:
A61K 35/50, A61L 27/38, C12N 5/073
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14896430

PKC-EPSILON INHIBITORS

IPC classification:
A61K 31/4468, A61K 31/46, A61P 25/00, A61P 25/18
Applicant:
The Regents of the University of California
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15774739

COLLAGEN REINFORCED TISSUE GRAFTS

IPC classification:
A61L 15/32, A61L 15/40, A61L 27/24, A61L 27/36, A61L 31/04
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15835106

HEAT CAPTURE, TRANSFER AND RELEASE FOR INDUSTRIAL APPLICATIONS

IPC classification:
F28D 15/02, F28D 15/04, F28D 15/06
Agent:
Mark Gibson, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16203661

PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME

IPC classification:
A01N 1/00, A61F 2/02, A61K 9/70, A61K 35/19, A61K 35/28, A61K 35/33, A61K 35/50, A61L 27/36, A61L 27/38, A61L 27/56
Agent:
Mark Gibson, Sagittarius IP
Status:
The application has been published
EP16190682

THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS

IPC classification:
A61K 38/08, A61P 3/14, A61P 5/00, A61P 5/20, C07K 7/06
Agent:
Mark Gibson, Sagittarius IP
Status:
The application has been published
EP15834396

POLYGALACTURONAN RHAMNOGALACTURONAN1 (PGRG1) COMPOSITION

IPC classification:
A01N 65/00, A61K 36/00, A61K 36/481, A61P 13/12, A61P 31/12
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15767389

MICRONIZED PLACENTAL TISSUE COMPOSITIONS WITH OPTIONAL SEALANT AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61L 26/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15841676

METHOD AND PANEL FOR DETERMINING ACUTE KIDNEY INJURY

IPC classification:
G01N 33/48, G01N 33/53
Applicant:
Yale University
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15844885

STATHERIN PEPTIDES

IPC classification:
A61K 9/10, A61K 38/17, A61P 1/02, A61P 19/08, C07K 7/06, C07K 7/08, C07K 14/47, C07K 17/04, C07K 19/00
Applicant:
University of Western Ontario (UWO)
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15790622

ERYTHROMELALGIA TREATMENT

IPC classification:
A61K 31/401, A61P 25/02, A61P 29/00, C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP16153978

INTRAOCULAR LENSES WITH QUANTUM DOTS

IPC classification:
A61F 2/16, A61L 27/50
Agent:
Mark Gibson, Sagittarius IP
Status:
The application has been published
EP15790624

PAROXYSMAL EXTREME PAIN DISORDER TREATMENT

IPC classification:
A61K 31/401, A61P 25/02, A61P 29/00, C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15790623

SMALL FIBRE NEUROPATHY TREATMENT

IPC classification:
A61K 31/401, A61P 25/02, C12Q 1/68
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15782205

CARRIER-ANTIBODY COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61P 35/00, B82Y 5/00, C07K 16/22, C07K 16/28, C07K 16/32
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15790220

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP

IPC classification:
C07K 7/08, A61K 47/50
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15816272

FENESTRATION KITS FOR MAKING FENESTRATED PLACENTAL TISSUE ALLOGRAFTS AND METHODS OF USING THE SAME

IPC classification:
A61L 27/36, A61L 27/56, A61L 27/60
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15809878

COMPOSITIONS AND METHODS FOR TREATING GLUTEN INTOLERANCE AND DISORDERS ARISING THEREFROM

IPC classification:
A61J 1/03, A61K 36/36, A61K 38/48, A61P 29/00, A61P 37/06
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15864244

METHODS AND COMPOSITIONS FOR POTENTIATING THE ACTION OF OPIOID ANALGESICS USING IBOGA ALKALOIDS

IPC classification:
A61P 25/36
Applicant:
DemeRx Inc
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15864346

ENERGY EFFICIENT WATER PURIFICATION AND DESALINATION

IPC classification:
C02F 9/00
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15868632

CARRIER MOLECULE COMPOSITIONS AND RELATED METHODS

IPC classification:
A61K 9/127, A61K 47/42, C07K 7/06, A61K 47/50
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15866475

METHODS AND MATERIALS FOR PREDICTING RESPONSE TO NIRAPARIB

IPC classification:
A61K 31/416, C12Q 1/68, G06F 19/22
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made
EP15865346

BIOMARKERS FOR DISTINGUISHING MOOD DISORDERS

IPC classification:
A61K 31/55, G01N 21/64, G01N 27/62, G01N 30/72, G01N 33/53, G01N 33/533, G01N 33/543, G01N 33/68
Agent:
Mark Gibson, Sagittarius IP
Status:
Request for examination was made

Please Sign in to use this feature